Paul Ashton

Paul Ashton

Company: Inflammasome Therapeutics

Job title: President & CEO


How do Inflammasomes, Key Molecular Regulators, Play a Vital Role in Dry AMD? 2:30 pm

Examine inflammasome activators in dry-AMD Explore inflammasome activation inhibitors in pre-clinical models Evaluate novel, recent clinical data Discuss the therapeutic strategy for inflammasome inhibition in dry-AMDRead more

day: Track 1 Day 2 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.